Congress of the European Crohn’s and Colitis Organization

March 4, 2015September 28, 2016

UC CARES Reveals Impact of Ulcerative Colitis on European Patients at 10th Congress of the European Crohn’s and Colitis Organisation

News

The pan-European Ulcerative Colitis Condition, Attitude, Resources and Educational Study (UC CARES) and Programme of Ulcerative Colitis Research Studies Utilising an Investigational Treatment (PURSUIT) presented their results on ulcerative colitis ... Read more

March 3, 2015March 3, 2015

European Ulcerative Colitis Patients Have Low Medication Adherence, Tillotts Pharma Survey Shows

News

More than 90% of the patients who suffer from ulcerative colitis in Europe have either low or medium adherence to their medication, which increases patients’ probability of suffering relapses up ... Read more

March 2, 2015March 2, 2015

Ferring Pharma Announces EU Launch Of CORTIMENT®MMX® (budesonide) For Ulcerative Colitis

News, Ulcerative colitis

Ferring Pharmaceuticals recently announced the European launch of CORTIMENT® MMX® (budesonide) to address active mild and moderate ulcerative colitis (UC) — the first and only approved oral drug for the disease. The company has ... Read more